Navigation Links
Half of the people suffering from head injuries fake to receive financial help
Date:1/11/2008

This release is available in Spanish.

How can it be proved that a patient is lying when they say that they have a cognitive problem, such as memory or concentration problems or anxiety" There are many people who exaggerate their injuries and even feign them in order to receive more money from insurance companies or obtain a sick leave, according to a pioneering research in Spain. This research was carried out in the Department of Personality, Assessment and Psychological Treatment University of Granada by Doctor Raquel Vilar Lpez. The conclusions of her study, which focused on patients who suffered from head injuries, speak for themselves: nearly half of the people who go to court feign psycho-cognitive disorders with the objective of profiting from this in some way. They are not hypochondriacs or overanxious or obsessive patients, they just lie in order to receive some sort of compensation, as for example money. They are the so called simulators.

Until now, in Spain no reliable system existed to detect if a person was faking their symptoms. For this reason the study by Vilar Lpez coordinated by Manuel Gmez Ro and Miguel Prez Garca is so important: for the first time, Spanish health professionals have a set of reliable tools to prove empirically if a patient is lying when they declare, for example, that their memory problems renders them unfit for work.

Validated Evidence

The work by this researcher has validated a series of tests which, when used on patients without them being aware of it, detect which patients are simulators and which are not. These neuropsychological tests were included in a three-hour-long battery of neuropsychological tests which assesses other cognitive aspects of the patient in order to disguise the actual tests and in this way obtain the desired information.

Raquel Vilar Lpez explains that in her research she adapted a series of tests that where already known in the United States a country with a long history of work in the field of neuropsychology to the Spanish context, because "the neuropsychological tests cannot be extrapolated without adjustments from a context to another. The percentage of patients who suffer from head injuries that feign symptoms is nearly the same as that obtained by the American researchers.

The study carried out in the UGR also included a method which has become very popular recently due to several television programs: the lie detector, an instrument which registers the physiological responses of blood pressure, heart beat, breathing rate and galvanic skin response. Vilar Lpez used this equipment with a group of 80 Psychology students as the analogous group, that is, as no patient would admit being a simulator, a group of people without any disorders were asked to fake them in order to confirm the validity of the test. Furthermore, 54 actual patients were analyzed by the doctor. These patients belonged to different departments of the University Hospital Virgen de las Nieves in Granada.

The researcher explains that although the lie detector itself has no scientific rigor, it could be an efficient instrument if combined with other tools, as for example the tests that we have validated. Part of the results of her research were presented at the last International Neuropsychological Society and National Academy of Neuropsychology conferences the two most important organizations in the field of neuropsychology in the world and in the prestigious scientific journal Archives of Clinical Neuropsychology.


'/>"/>

Contact: Raquel Vilar Lpez
raquelvilarlopez@hotmail.com
34-699-407-282
Universidad de Granada
Source:Eurekalert

Related biology news :

1. Plants can be used to study how and why people respond differently to drugs
2. Fungus genome yielding answers to protect grains, people and animals
3. People who skip meals: are they better off?
4. Energy drinks may pose risks for people with high blood pressure, heart disease
5. Ozone can affect heavier people more
6. Rising food prices threaten worlds poor people
7. New study finds biodiversity conservation secures ecosystem services for people
8. 100 percent of people carry at least 1 type of pesticide
9. New Actemra data shows significant benefit for patients suffering from rheumatoid arthritis
10. Rutgers Genetics receives $7.8 million for autism research
11. Herr receives Heinz Award for Technology, the Economy and Employment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2016)... R.I. , March 31, 2016  Genomics firm ... of founding CEO, Barrett Bready , M.D., who ... members of the original technical leadership team, including Chief ... President of Product Development, Steve Nurnberg and Vice President ... returned to the company. Dr. Bready served ...
(Date:3/23/2016)... March 23, 2016 ... Sicherheit Gesichts- und Stimmerkennung mit Passwörtern ... (NASDAQ: MESG ), ein führender Anbieter ... Unternehmen mit SpeechPro zusammenarbeitet, um erstmals dessen ... wird die Möglichkeit angeboten, im Rahmen mobiler ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of commercial spectrophotometers and fluorometers ... the 6000i models are higher end machines that use the more unconventional z-dimension of ... beam from the bottom of the cuvette holder. , FireflySci has developed several ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: